Table 1. Summary of Samples Used in the Discovery and Validation Sets.
| number of subjects | male | female | age | ||
|---|---|---|---|---|---|
| discovery | control (healthy) | 56 | 26 | 30 | 23–91 |
| NASH | 23 | 10 | 13 | 45–70 | |
| HCC | 19 | 15 | 4 | 32–85 | |
| validation | control (benign hepatic mass) | 28 | 16 | 12 | 52–71 |
| HCC | 28 | 20 | 8 | 47–77 |